137 related articles for article (PubMed ID: 11146549)
21. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
22. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
Krane IM; Leder P
Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
[TBL] [Abstract][Full Text] [Related]
23. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
24. Progesterone receptors in the mouse mammary duct: distribution and developmental regulation.
Silberstein GB; Van Horn K; Shyamala G; Daniel CW
Cell Growth Differ; 1996 Jul; 7(7):945-52. PubMed ID: 8809412
[TBL] [Abstract][Full Text] [Related]
25. Active signaling by Neu in transgenic mice.
DiGiovanna MP; Lerman MA; Coffey RJ; Muller WJ; Cardiff RD; Stern DF
Oncogene; 1998 Oct; 17(14):1877-84. PubMed ID: 9778054
[TBL] [Abstract][Full Text] [Related]
26. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
27. Loss of Alx4, a stromally-restricted homeodomain protein, impairs mammary epithelial morphogenesis.
Joshi PA; Chang H; Hamel PA
Dev Biol; 2006 Sep; 297(1):284-94. PubMed ID: 16916507
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Ménard S
Cancer Res; 2005 Feb; 65(3):1071-8. PubMed ID: 15705909
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of Muc1 in MMTV-c-Neu tumors.
Adriance MC; Gendler SJ
Oncogene; 2004 Jan; 23(3):697-705. PubMed ID: 14737104
[TBL] [Abstract][Full Text] [Related]
30. Ontogenic and nutritional regulation of steroid receptor and IGF-I transcript abundance in the prepubertal heifer mammary gland.
Meyer MJ; Rhoads RP; Capuco AV; Connor EE; Hummel A; Boisclair YR; Van Amburgh ME
J Endocrinol; 2007 Oct; 195(1):59-66. PubMed ID: 17911397
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
Kirma N; Gill K; Mandava U; Tekmal RR
Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
[TBL] [Abstract][Full Text] [Related]
32. SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice.
Li H; Rajendran GK; Liu N; Ware C; Rubin BP; Gu Y
Breast Cancer Res; 2007; 9(1):R1. PubMed ID: 17201918
[TBL] [Abstract][Full Text] [Related]
33. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
Sampayo R; Recouvreux S; Simian M
Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
[TBL] [Abstract][Full Text] [Related]
34. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland.
Johnson MD; Kenney N; Stoica A; Hilakivi-Clarke L; Singh B; Chepko G; Clarke R; Sholler PF; Lirio AA; Foss C; Reiter R; Trock B; Paik S; Martin MB
Nat Med; 2003 Aug; 9(8):1081-4. PubMed ID: 12858169
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis.
Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R
Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933
[TBL] [Abstract][Full Text] [Related]
36. Protein expression profiling of primary mammary epithelial cells derived from MMTV-neu mice revealed that HER2/NEU-driven changes in protein expression are functionally clustered.
Park S; Lee KM; Ju JH; Kim J; Noh DY; Lee T; Shin I
IUBMB Life; 2010 Jan; 62(1):41-50. PubMed ID: 19960538
[TBL] [Abstract][Full Text] [Related]
37. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice.
Atwood CS; Hovey RC; Glover JP; Chepko G; Ginsburg E; Robison WG; Vonderhaar BK
J Endocrinol; 2000 Oct; 167(1):39-52. PubMed ID: 11018751
[TBL] [Abstract][Full Text] [Related]
38. ErbB2 is required for ductal morphogenesis of the mammary gland.
Jackson-Fisher AJ; Bellinger G; Ramabhadran R; Morris JK; Lee KF; Stern DF
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17138-43. PubMed ID: 15569931
[TBL] [Abstract][Full Text] [Related]
39. Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells.
Lee HJ; Gallego-Ortega D; Ledger A; Schramek D; Joshi P; Szwarc MM; Cho C; Lydon JP; Khokha R; Penninger JM; Ormandy CJ
Development; 2013 Apr; 140(7):1397-401. PubMed ID: 23462470
[TBL] [Abstract][Full Text] [Related]
40. HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis.
Tekmal RR; Nair HB; Perla RP; Kirma N
J Steroid Biochem Mol Biol; 2007; 106(1-5):111-8. PubMed ID: 17604617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
